C
C

Price • Centessa Pharmaceuticals

CNTA

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

Historical stock price chart and annual return over the past years

-40%

4 years

% Total

CNTA
-12%

4 years

Annual Return

CNTA